Flahy Inc. is developing a platform that utilizes knowledge graphs to assist in clinical decision-making. The company aims to connect biological and clinical data to provide personalized healthcare recommendations for prevention and treatment.
Founder and CEO Jagjit Singh stated that the company has spent years building a graph-based database and training models to identify relationships between data points. The system is designed to interpret complex information, such as genetic mutations and cholesterol markers, to determine appropriate treatment paths.
The company collaborates with graph technology providers, including Neo4j Inc., to manage its data infrastructure. A key focus for Flahy is integrating longitudinal data from wearable devices into its graphs to track health changes over time.
Flahy currently offers a consumer-facing product called FlahyLife, which combines biological and health information to guide users. The company is also working with clinical laboratories and health systems to deploy its platform for closing care gaps and improving diagnostic accuracy.
